News tagged with rna interference
New RNA-based therapeutic strategies for controlling gene expression
Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which ...
Feb 02, 2012 |
not rated yet |
0
Using plants to silence insect genes in a high-throughput manner
Scientists at the Max Planck Institute for Chemical Ecology, Germany, are now using a procedure which brings forward ecological research on insects: They study gene functions in moth larvae by manipulating ...
Feb 02, 2012 |
5 / 5 (2) |
1
|
Study offers new information for flu fight
Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways that the flu uses for replication, ...
Jan 27, 2012 |
5 / 5 (2) |
0
|
Gold nanorods could improve radiation therapy of head and neck cancer
Radiation therapy is an important part of head and neck cancer therapy, but most head and neck tumors have a built-in mechanism that makes them resistant to radiation. As a result, oncologists have to deliver huge doses of ...
Nanotechnology / Bio & Medicine
Jan 20, 2012 |
5 / 5 (3) |
1
|
Investigators achieve important step toward treating Huntington's disease
A team of researchers at the UC Davis Institute for Regenerative Cures has developed a technique for using stem cells to deliver therapy that specifically targets the genetic abnormality found in Huntington's disease, a hereditary ...
Medicine & Health / Neuroscience
Jan 19, 2012 |
not rated yet |
0
|
Researchers solve a protein complex's molecular structure to explain its role in gene silencing
A cell's genome maintains its integrity by organizing some of its regions into a super-compressed form of DNA called heterochromatin. In the comparatively simple organism fission yeast, a cellular phenomenon known as RNA ...
Nov 13, 2011 |
not rated yet |
0
|
From genomic data to new cancer drug
New discoveries about follicular lymphoma, a currently intractable form of cancer, highlight the power of functional genomics in cancer gene discovery. A report in the Oct 28th issue of Cell demonstrates how genetic insigh ...
Oct 27, 2011 |
not rated yet |
0
CHEO scientist advances biotherapeutics as published in Cancer Cell
Oncolytic virology uses live viruses to sense the genetic difference between a tumor and normal cell. Once the virus finds a tumor cell, it replicates inside that cell, kills it and then spreads to adjacent tumor cells to ...
Oct 18, 2011 |
not rated yet |
0
Novel technique uses RNA interference to block inflammation
Massachusetts General Hospital (MGH) researchers along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals have found a way to block, in an animal model, the damaging ...
Oct 09, 2011 |
5 / 5 (7) |
0
|
New findings contribute to understanding of diabetic kidney disease
A gene called PVT1 may help reduce the kidneys ability to filter blood, leading to kidney disease, kidney failure and death, according to a study published today by researchers at the Translational Genomics Research Institute ...
Apr 23, 2011 |
not rated yet |
0
Team perfects non-lethal way of switching off essential genes in mice
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will ...
Apr 14, 2011 |
5 / 5 (3) |
5
|
'Good cholesterol' nanoparticles seek and destroy cancer cells
High-density lipoprotein's hauls excess cholesterol to the liver for disposal, but new research suggests "good cholesterol" can also act as a special delivery vehicle of destruction for cancer.
Nanotechnology / Bio & Medicine
Apr 01, 2011 |
5 / 5 (8) |
2
|
Suggesting genes' friends, Facebook-style
Scientists at the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Centre (DKFZ), both in Heidelberg, Germany, have developed a new method that uncovers the combined effects of genes. ...
Mar 07, 2011 |
5 / 5 (2) |
0
|
New method powerfully boosts efficiency of RNA interference (RNAi) in shutting down genes
A research team led by scientists at Cold Spring Harbor Laboratory (CSHL) has developed a powerful method that allows them to sift through thousands of candidate hairpin-shaped RNA molecules at a time and pull out only those ...
Feb 24, 2011 |
5 / 5 (1) |
0
UMMS and Lundbeck to explore potential targeted therapy for Huntington's disease
The University of Massachusetts Medical School (UMMS) and Lundbeck Inc. today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease (HD).
Jan 28, 2011 |
not rated yet |
0
RNA interference
RNA interference (RNAi) is a system within living cells that helps to control which genes are active and how active they are. Two types of small RNA molecules – microRNA (miRNA) and small interfering RNA (siRNA) – are central to RNA interference. RNAs are the direct products of genes, and these small RNAs can bind to specific other RNAs and either increase or decrease their activity, for example by preventing a messenger RNA from producing a protein. RNA interference has an important role in defending cells against parasitic genes – viruses and transposons – but also in directing development as well as gene expression in general.
The RNAi pathway is found in many eukaryotes including animals and is initiated by the enzyme Dicer, which cleaves long double-stranded RNA (dsRNA) molecules into short fragments of ~20 nucleotides. One of the two strands of each fragment, known as the guide strand, is then incorporated into the RNA-induced silencing complex (RISC). The most well-studied outcome is post-transcriptional gene silencing, which occurs when the guide strand base pairs with a complementary sequence of a messenger RNA molecule and induces cleavage by Argonaute, the catalytic component of the RISC complex. This process is known to spread systemically throughout the organism despite initially limited molar concentrations of siRNA.
The selective and robust effect of RNAi on gene expression makes it a valuable research tool, both in cell culture and in living organisms because synthetic dsRNA introduced into cells can induce suppression of specific genes of interest. RNAi may also be used for large-scale screens that systematically shut down each gene in the cell, which can help identify the components necessary for a particular cellular process or an event such as cell division. Exploitation of the pathway is also a promising tool in biotechnology and medicine.
Historically, RNA interference was known by other names, including post transcriptional gene silencing, and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. In 2006, Andrew Fire and Craig C. Mello shared the Nobel Prize in Physiology or Medicine for their work on RNA interference in the nematode worm C. elegans, which they published in 1998.
For more information about RNA interference, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.